Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter. type and insertion time:: Evidence from a meta-analysis

被引:89
作者
Walder, B
Pittet, D
Tramèr, MR
机构
[1] Univ Geneva Hosp, Div Surg Intens Care, CH-1211 Geneva 14, Switzerland
[2] Univ Geneva Hosp, Div Anaesthesiol, Dept APSIC, CH-1211 Geneva, Switzerland
[3] Univ Geneva Hosp, Dept Internal Med, Infect Control Program, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1086/502005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To test the evidence that the risk of infection related to central venous catheters (CVCs) is decreased by anti-infective coating or cuffing. DESIGN: Systematic review of randomized, controlled trials comparing anti-infective with inactive (control) CVCs. INTERVENTIONS: Average insertion times were taken as a measurement of the length of insertion. Dichotomous data were combined using a fixed effect model and expressed as odds ratio (OR) with 95% confidence interval (CI95). RESULTS: Two trials on antibiotic coating (343 CVCs) had an average insertion time of 6 days; the risk of BSI decreased from 5.1% with control to 0% with anti-infective catheters. There were no trials with longer average insertion times. In three trials on silver collagen cuffs (422 CVCs), the average insertion time ranged from 5 to 8.2 days (median, 7 days); the risk of BSI was 5.6% with control and 3.2% with anti-infective catheters. In another trial on silver collagen cuffs (101 CVCs), the average insertion time was 38 days; the risk of BSI was 3.7% with control and 4.3% with anti-infective catheters. In five trials on chlorhexidine-silver sulfadiazine coating (1,269 CVCs), the average insertion time ranged from 5.2 to 7.5 days (median, 6 days); the risk of BSI decreased from 4.1% with control to 1.9% with anti-infective catheters. In five additional trials on chlorhexidine-silver sulfadiazine coating (1,544 CVCs), the average insertion time ranged from 7.8 to 20 days (median, 12 days); the risk of BSI was 4.5% with control and 4.2% with anti-infective catheters. CONCLUSIONS: Antibiotic and chlorhexidine-silver sulfadiazine coatings are anti-infective for short (approximately 1 week) insertion times. For longer insertion times, there are no data on antibiotic coating, and there is evidence of lack of effect for chlorhexidine-silver sulfadiazine coating. For silver-impregnated collagen cuffs, there is evidence of lack of effect for both short- and long-term insertion.
引用
收藏
页码:748 / 756
页数:9
相关论文
共 55 条
[1]  
[Anonymous], AM J MED
[2]  
[Anonymous], 1998, HOSP INFECT
[3]   CONSEQUENCES OF INTRAVASCULAR CATHETER SEPSIS [J].
ARNOW, PM ;
QUIMOSING, EM ;
BEACH, M .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (06) :778-784
[4]   A PROSPECTIVE RANDOMIZED TRIAL COMPARING THE SILVER-IMPREGNATED COLLAGEN CUFF WITH THE BEDSIDE TUNNELED SUBCLAVIAN CATHETER [J].
BABYCOS, CR ;
BARROCAS, A ;
WEBB, WR .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1993, 17 (01) :61-63
[5]   Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters [J].
Bach, A ;
Schmidt, H ;
Bottiger, B ;
Schreiber, B ;
Bohrer, H ;
Motsch, J ;
Martin, E ;
Sonntag, HG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) :315-322
[6]   Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients [J].
Bach, A ;
Darby, D ;
Bottiger, B ;
Bohrer, H ;
Motsch, J ;
Martin, E .
INTENSIVE CARE MEDICINE, 1996, 22 (10) :1066-1069
[7]   Scanning electron microscopic investigation of catheters for blood access [J].
Bambauer, R ;
Schiel, R ;
Mestres, P ;
Klinkmann, J ;
Sioshansi, P .
BLOOD PURIFICATION, 1996, 14 (03) :249-256
[8]   Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter [J].
Böswald, M ;
Lugauer, S ;
Regenfus, A ;
Braun, GG ;
Martus, P ;
Geis, C ;
Scharf, J ;
Bechert, T ;
Greil, J ;
Guggenbichler, JP .
INFECTION, 1999, 27 (Suppl 1) :S56-S60
[9]  
Ciresi DL, 1996, AM SURGEON, V62, P641
[10]   A CONTROLLED TRIAL OF SCHEDULED REPLACEMENT OF CENTRAL VENOUS AND PULMONARY-ARTERY CATHETERS [J].
COBB, DK ;
HIGH, KP ;
SAWYER, RG ;
SABLE, CA ;
ADAMS, RB ;
LINDLEY, DA ;
PRUETT, TL ;
SCHWENZER, KJ ;
FARR, BM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15) :1062-1068